Molecule intelOpportunity: LowerEssential

Itraconazole

99 brands · 72 companies · product forms

ATC: J02AC02

Opportunity snapshot

Launch attractiveness
29
Market saturation
90
Price room
68
Regulatory risk
0
99
brands
72
companies
Rs 582.44
median price
86
price points
3.72x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 3%

Price room

Across observed sources and strengths
CheapestRs 232.75
MedianRs 582.44
Most expensiveRs 864.68
Spread3.72×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 3.72x across 86 trusted points (Rs 232.75-864.68). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Itraconazole — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(68) + 20% low-competition(10) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

72 canonical companies and 99 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 3.72x across 86 trusted points (Rs 232.75-864.68). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Full coverage.

Packaged brief for this lower opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.